Cargando…
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
The management of advanced castration resistant prostate cancer (CRPC) has been rapidly changing and is still evolving. In the last years, there has been an increasing knowledge of prostate cancer biology. New therapeutic agents and approaches have been evaluated demonstrating benefits in survival a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708230/ https://www.ncbi.nlm.nih.gov/pubmed/26816835 http://dx.doi.org/10.3978/j.issn.2223-4683.2015.04.11 |